Asia-Pacific Vitreo-Retina (APVRS) 2022
Safety of intravitreal pegcetacoplan in geographic atrophy: 24 month results from the OAKS and DERBY phase 3 trials
Efficacy of intravitreal pegcetacoplan in geographic atrophy: 24 month results from the OAKS and DERBY phase 3 trials
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.